Cargando…

Predicting Gleason score using the initial serum total prostate-specific antigen in Black men with symptomatic prostate adenocarcinoma in Nigeria

BACKGROUND: Men of Black African descent are known to have the highest incidence of prostate cancer. The disease is also more aggressive in this group possibly due to biologically more aggressive tumor or late presentation. Currently, serum prostate-specific antigen (PSA) assay plays a significant r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nnabugwu, Ikenna I, Udeh, Emeka I, Ugwumba, Fredrick O, Ozoemena, Francis O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957636/ https://www.ncbi.nlm.nih.gov/pubmed/27486316 http://dx.doi.org/10.2147/CIA.S98232

Ejemplares similares

Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria
por: Udeh, Emeka I., et al.
Publicado: (2016)

Serum total prostate-specific antigen values in men with symptomatic prostate enlargement in Nigeria: role in clinical decision-making
por: Nnabugwu, Ikenna I, et al.
Publicado: (2014)

Prostate Cancer Detected by Screening in a Semi Urban Community in Southeast Nigeria: Correlations and Associations between Anthropometric Measurements and Prostate-specific Antigen
por: Ugwumba, Fred O, et al.
Publicado: (2017)

The relationship between prevalence and severity of lower urinary tract symptoms (LUTS), and body mass index and mid-abdominal circumference in men in a resource-poor community in Southeast Nigeria: a cross-sectional survey
por: Nnabugwu, Ikenna I., et al.
Publicado: (2019)

Informed consent for clinical treatment in low-income setting: evaluating the relationship between satisfying consent and extent of recall of consent information
por: Nnabugwu, Ikenna I., et al.
Publicado: (2017)

Prostate Cancer Characteristics: A Descriptive Analysis of Clinical Features at Presentation in the Last Decade in a Black African Community
por: Ugwumba, Fredrick O., et al.
Publicado: (2022)

Reducing the burden of regular indwelling urinary catheter changes in the catheter clinics: the opinion of patients and relatives on the practice of self-catheterization
por: Nnabugwu, Ikenna I, et al.
Publicado: (2014)

A cost effective analysis of fixed-dose combination of dutasteride and tamsulosin compared with dutasteride monotherapy for benign prostatic hyperplasia in Nigeria: a middle income perspective; using an interactive Markov model
por: Udeh, Emeka I., et al.
Publicado: (2016)

Prevalence of, and Risk Factors for Erectile Dysfunction in Male Type 2 Diabetic Outpatient Attendees in Enugu, South East Nigeria
por: Ugwumba, Fred O., et al.
Publicado: (2018)

Paratesticular myxoid liposarcoma in a 23-year old Nigerian
por: Ugwumba, Fred O, et al.
Publicado: (2010)

Correlation between Body Mass Index and Gleason Score in Men with Prostate Cancer in Southeastern Nigeria
por: Nwadi, Uchenna Victor, et al.
Publicado: (2021)

Correlations Between Intratumoral Interstitial Fibrillary Network and Vascular Network in Gleason Patterns of Prostate Adenocarcinoma
por: PLEȘEA, R.M., et al.
Publicado: (2015)

Expression of stromal elements of prostatic adenocarcinoma in different gleason scores
por: Osorio, Clarice Fraga Esteves Maciel, et al.
Publicado: (2019)

Biochemical Recurrence in Gleason Score 7 Prostate Cancer in Korean Men: Significance of the Primary Gleason Grade
por: Ro, Yun Kwan, et al.
Publicado: (2012)

Lower urinary tract symptoms in men: challenges to early hospital presentation in a resource-poor health system
por: Nnabugwu, Ikenna I., et al.
Publicado: (2020)

Prognostic factors in Japanese men with high-Gleason metastatic castration-resistant prostate cancer
por: Nishimoto, Mitsuhisa, et al.
Publicado: (2022)

Evaluation of Cytokeratin-7 and Cytokeratin-19 Expression Relationship with Gleason Score in Prostatic Adenocarcinoma
por: Soltanipur, Masood, et al.
Publicado: (2023)

Incidence of metastasis and prostate-specific antigen levels at diagnosis in Gleason 3+4 versus 4+3 prostate cancer
por: Kamel, Mohamed H., et al.
Publicado: (2018)

Does prostate acinar adenocarcinoma with Gleason Score 3 + 3 = 6 have the potential to metastasize?
por: Montironi, Rodolfo, et al.
Publicado: (2014)

The gut microbiota associated with high‐Gleason prostate cancer
por: Matsushita, Makoto, et al.
Publicado: (2021)

Gleason 6 prostate cancer: That which cannot be named
por: Burke, Harry B.
Publicado: (2022)

The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6
por: Wang, Hanfeng, et al.
Publicado: (2017)

Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer
por: Lehrer, S, et al.
Publicado: (2002)

Increased aPKC Expression Correlates with Prostatic Adenocarcinoma Gleason Score and Tumor Stage in the Japanese Population
por: Perry, Anthony S., et al.
Publicado: (2014)

MYC DNA Methylation in Prostate Tumor Tissue is Associated with Gleason Score
por: Barry, Kathryn Hughes, et al.
Publicado: (2020)

Validation of the WHO 2016 new Gleason score of prostatic carcinoma
por: Rao, Vishal, et al.
Publicado: (2018)

Multimodal Radiomic Features for the Predicting Gleason Score of Prostate Cancer
por: Chaddad, Ahmad, et al.
Publicado: (2018)

Beyond the Gleason score: the prognostic significance of prostate cancer subtypes
por: Flood, Trevor A., et al.
Publicado: (2018)

Clinical significance of subtypes of Gleason pattern 4 prostate cancer
por: Hassan, Oudai, et al.
Publicado: (2018)

Associations of Prostate-Specific Antigen, Prostate Carcinoma Tissue Gleason Score, and Androgen Receptor Expression with Bone Metastasis in Patients with Prostate Carcinoma
por: Chen, Yehui, et al.
Publicado: (2017)

Analysis of monotherapy prostate brachytherapy in patients with prostate cancer. Initial PSA and Gleason are important for recurrence?
por: Galego, Pedro, et al.
Publicado: (2015)

Impact of Gleason Pattern 5 on outcomes of patients with prostate cancer and iodine-125 prostate brachytherapy
por: Makino, Tomoyuki, et al.
Publicado: (2016)

Association of Age With Risk of Adverse Pathological Findings at Radical Prostatectomy in Men With Gleason Score 6 Prostate Cancer
por: Kim, Daniel W., et al.
Publicado: (2020)

Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
por: Vesalainen, S., et al.
Publicado: (1994)

Prostatic Adenocarcinoma: A Grading from Gleason to the New Grade-Group System: A Historical and Critical Review
por: Barakzai, Muhammad Abrar
Publicado: (2019)

Differences in survival of prostate cancer Gleason 8–10 disease and the establishment of a new Gleason survival grading system
por: Zhou, Yuan, et al.
Publicado: (2020)

Prostate-Specific Antigen Density and Gleason Score Predict Adverse Pathologic Features in Patients with Clinically Localized Prostate Cancer
por: Nowroozi, Mohammad Reza, et al.
Publicado: (2016)

Correlation of Gleason Scores with Diffusion-Weighted Imaging Findings of Prostate Cancer
por: Nagarajan, Rajakumar, et al.
Publicado: (2012)

Correlation of concentrations of selected trace elements with Gleason grade of prostate tissues
por: Banas, A., et al.
Publicado: (2010)

Predicting Gleason Score of Prostate Cancer Patients Using Radiomic Analysis
por: Chaddad, Ahmad, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ab8io4thugdj0glsla3da9du26